Influence of mineral phase in mineralization of a biocomposite containing chitosan,demineralized bone matrix and bone ash—in vitro study

A resorbable composite which acts as a active barrier in guided bone regeneration was fabricated using chitosan, demineralized bone matrix and bone ash. Its potential to form bone like apatite in simulated body fluid was assessed in this study. The mechanical strength of these composites was correlated with bone ash ratios and composites with better tensile strength were studied for their acellular bioactivity by incubating in simulated body fluid for 21 days. Composites without bone ash did not show acellular bioactivity which was confirmed by thermogravimetric analysis. In case of biocomposites with bone ash, there was an increase in residual weight indicating the mineralization of the composite. The composite containing bone ash has shown the peaks related to phosphate vibrations in its Fourier-transform infrared spectrum. Scanning micrographs revealed formation of apatite like crystals on its surface. Ca/P ratio was found to be 1·7 which is nearer to that of natural bone. Thus, prepared composites can be used as resorbable biocomposite in maxillofacial and oral defects.     

In vitro physicochemical properties, osteogenic activity, and immunocompatibility of calcium silicate-gelatin bone grafts for load-bearing applications

The use of a composite made of natural polymer gelatin and bioactive calcium silicate resembling the morphology and properties of natural bone may provide a solution to the problem of ceramic brittleness for load-bearing applications. The in vitro bioactivity, degradability, osteogenic activity, and immunocompatibility of three types of calcium silicate-gelatin composite bone grafts were characterized. The osteogenic activity and immunocompatibility were evaluated by incubating the bone grafts with human dental pulp cells. After soaking in a simulated body fluid (SBF) for 1 day, all materials were covered with clusters of "bone-like" apatite spherulites. The control material without gelatin exhibited an insignificant change in strength, degradability, and porosity and a small weight loss of 6% after 180 days of soaking in the SBF solution. In contrast, the soaking time imposed in this study did have a statistically significant effect on compressive strength, porosity, and weight loss of the gelatin-containing composites. After 180 days of soaking, the composite with 10 wt % gelatin lost 47% and 10% in compressive strength and weight, respectively, with a porosity of 23%. However, the presence of gelatin promoted greater cell attachment and proliferation on the composite bone grafts. Pulp cells on the calcium silicate-gelatin bone grafts expressed higher levels of osteocalcin, osteopontin, and bone sialoprotein. The inhibition of inducible nitric oxide synthase and interleukin-1 expression and the activation of interleukin-10 were increased with increasing gelatin content. Overall, these findings provide evidence that composite bone grafts containing 10 wt % gelatin with a high initial strength were bioactive, nontoxic, and osteogenic and may be able to promote bone healing for load-bearing applications.     

粉末冶金法制备Ti/HA生物复合材料的体内生物活性

采用粉末冶金法制备了Ti/HA复合材料,对其体内生物活性进行了研究。植入早期,纯Ti种植体周围有一层纤维组织形成,纤维膜随着种植时间的延长逐渐消失,并伴随有新骨形成,植入6个月后,纯Ti与周围骨组织之间形成典型的骨接触界面。含钛量为30％的复合材料周围在植入早期有很薄一层新骨形成,种植体与周围骨组织之间存在很大的空隙,含钛量为50％和70％的复合材料周围则有大量的新骨形成,植入6个月后三种复合材料均与周围骨组织之间形成了牢固的骨性结合界面。可见,三种Ti/HA复合材料均具有良好的生物活性。但含钛量为30％的复合材料成骨速度明显低于另两种复合材料。三种Ti/HA复合材料的生物活性均大于纯Ti。     

Development of degradable and bioactive composite as bone implants by incorporation of mesoporous bioglass into poly(l-lactide)

Bioactive composites containing mesoporous bioglass (MBG) and poly(l-lactide) (PLLA) for bone regeneration were fabricated by solution casting method. The results showed that the compressive strength and hydrophilicity of the MBG/PLLA composites significantly improved with the increase of MBG content. In addition, the weight loss ratio of the composites in Tris–HCl solution was obviously enhanced with the increase of MBG content. Moreover, the composite containing MBG could compensate for the decrease of pH value by neutralizing the acidic products from PLLA degradation in the Tris–HCl solution. Furthermore, the MBG/PLLA composites could induce apatite formation on their surfaces after soaked into simulated body fluid (SBF), indicating good bioactivity. In cell culture experiments, the results showed that the composite could enhance cell attachment, proliferation and alkaline phosphatase activity (ALP) of MC3T3-E1 cells, and the improvements were dependent on the MBG content in the composites. In short, the MBG/PLLA biocomposites with improved properties of hydrophilicity, degradability, bioactivity, neutralizing acidic degradable products and good cytocompatibility would be a promising orthopedic implant material for bone repair application.     

Bioresorbable and bioactive composite materials based on polylactide foams filled with and coated by Bioglass® particles for tissue engineering applications

Poly(DL-lactide) (PDLLA) foams and bioactive glass (Bioglass®) particles were used to form bioresorbable and bioactive composite scaffolds for applications in bone tissue engineering. A thermally induced phase separation process was applied to prepare highly porous PDLLA foams filled with 10 wt % Bioglass® particles. Stable and homogeneous layers of Bioglass® particles on the surface of the PDLLA/Bioglass® composite foams as well as infiltration of Bioglass® particles throughout the porous network were achieved using a slurry-dipping technique. The quality of the bioactive glass coatings was reproducible in terms of thickness and microstructure. In vitro studies in simulated body fluid (SBF) were performed to study the formation of hydroxyapatite (HA) on the surface of the PDLLA/Bioglass® composites, as an indication of the bioactivity of the materials. Formation of the HA layer after immersion in SBF was confirmed by X-ray diffraction and Raman spectroscopy measurements. The rate of HA formation in Bioglass®-coated samples was higher than that observed in non-coated samples. SEM analysis showed that the HA layer thickness rapidly increased with increasing time in SBF in the Bioglass®-coated samples. The high bioactivity of the developed composites suggests that the materials are attractive for use as bioactive, resorbable scaffolds in bone tissue engineering.     

Development of carbon nanofiber reinforced hydroxyapatite with enhanced mechanical properties

In order to improve fracture toughness, carbon nanofibers (CNF) were used as reinforcement for hydroxyapatite (HA) composites. The powder mixture of CNF/HA were obtained with ball-milling technique. CNF/HA composites were sintered by hot-pressing with 7.81 and 15.6 MPa sintering pressure. Maximum sintering pressure was 1200 °C. Mechanical and physiological bio-compatibility were evaluated by four-point bending tests, indentation tests and immersion tests in simulated body fluid (SBF). The strength values of 10 vol.% CNF/HA composites sintered at 15.6 MPa is 90 MPa, which is within those of cortical bone. The fracture toughness values for CNF/HA composites are around 1.6 times higher than those obtained for HA. Equal bioactivity are obtained for CNF/HA composites.     

Preparation and characterization of hydroxyapatite/polycaprolactone–chitosan composites

Hydroxyapatite (HA)/polycaprolactone (PCL)–chitosan (CS) composites were prepared by melt-blending. For the composites, the amount of HA was varied from 0% to 30% by weight. The morphology, structure and component of the composites were evaluated using environmental scanning electron microscope, X-ray diffraction and Fourier transform infrared spectroscope. The tensile properties were evaluated by tensile test. The bioactivity and degradation property were investigated after immersing in simulated body fluid (SBF) and physiological saline, respectively. The results show that the addition of HA to PCL–CS matrix tends to suppress the crystallization of PCL but improves the hydrophilicity. Adding HA to the composites decreases the tensile strength and elongation at break but increases the tensile modulus. After immersing in SBF for 14 days, the surface of HA/PCL–CS composites are covered by a coating of carbonated hydroxyapatite with low crystallinity, indicating the excellent bioactivity of the composites. Soaking in the physiological saline for 28 days, the molecular weight of PCL decreases while the mass loss of the composites and pH of physiological saline increase to 5.86% and 9.54, respectively, implying a good degradation property of the composites.     

In vitro evaluation of hydroxyapatite reinforced polyhydroxybutyrate composite

Particulate hydroxyapatite (HA) was incorporated into polyhydroxybutyrate (PHB) to form a bioactive and biodegradable composite for applications in hard tissue replacement and regeneration. HA/PHB composite containing 10, 20, and 30 vol.% of HA was made for in vitro evaluation. In vitro studies were conducted using an acellular simulated body fluid (SBF). Composite specimens were immersed in SBF at 37 °C for various periods of time prior to surface analysis and mechanical testing. Results obtained from scanning electron microscopic (SEM) examination, thin film X-ray diffraction (TF-XRD) analysis, and Fourier transform infrared (FTIR) spectroscopy showed that a layer of bone-like apatite formed within a short period on HA/PHB composite after its immersion in SBF, demonstrating high in vitro bioactivity of the composite. The bioactivity and mechanical properties of the composite could be changed by varying the amount of HA in the composite. Dynamic mechanical analysis (DMA) revealed that the storage modulus (E′) of HA/PHB composite increased initially with immersion time in SBF, due to apatite formation on composite surface and decreased after prolonged immersion in SBF, indicating degradation of the composite in a simulated body environment. HA/PHB composite thus has the potential for its intended applications.     

Wet chemical process to enhance osteoconductivity of electrospun chitosan nanofibers

In this study, chitosan/hydroxyapatite (CS/HA) nanofibers were prepared using a wet chemical method. First, CS nanofibers with uniform diameters were fabricated using electrospinning. Then, a wet chemical process was used to mineralize nanofiber surfaces to form a homogeneous HA deposit. Reactions with three cycles were found to optimize biomimetic properties of the HA. The mineralization process required only approximately 3 h, which corresponded to a saving of 98 % in preparation time compared with that needed by the process using a simulated body fluid (SBF). According to the attachment and spreading of UMR (rat osteosarcoma) cells on the CS/HA composite fibers, the deposited mineralization layer significantly enhanced cell affinity of the CS nanofibers and the HA created by the wet chemical method was as effective as that created by the SBF. The composite nanofibrous scaffolds produced by the wet chemical process also promoted osteogenic differentiation by inducing ossification. Thus, expressions of collagen type I, alkaline phosphatase, osteocalcin, bone sialoprotein, and osterix were all enhanced. These results demonstrated that composite electrospun fibers can be efficiently prepared using wet chemical method and the resulting nanofibrous scaffolds have considerable potential in future bone tissue engineering applications.     

Fabrication and corrosion behavior of HA/Mg-Zn biocomposites

The thermal-treated hydroxyapatite (HA) particles, Mg and Zn powders were used to prepare the HA/Mg-Zn composites with different HA contents by means of powder metallurgy technology. The microstructures, formation phases, and corrosion behaviors in simulated body fluid (SBF) were studied in comparison with pure magnesium and HA/Mg composites fabricated by the same preparation technology. As a result, no evident reaction happened between HA particles and Mg matrix during sintering process, and Zn atoms diffused into Mg matrix to form a single phase Mg-Zn alloy matrix. The addition of HA particles changed the corrosion mechanism of Mg matrix. During the corrosion process, HA particles would adsorb and Ca²⁺ ions efficiently and induce the deposition of Ca-P compounds on the surface of composites. HA could improve the corrosion resistance of magnesium matrix composites in SBF and restrain the increase of pH of SBF. Furthermore, the addition of Zn was favorable to improve the corrosion resistance of HA/Mg composites due to the densification of composites and the formation of Mg-Zn alloy matrix.     

Bioglass® coated poly(DL‐lactide) foams for tissue engineering scaffolds

The purpose of this study was to prepare poly(DL‐lactic acid) (PDLLA)/Bioglass® composites of foam‐like structure, to measure the degree of bioactivity of the composites by studying the formation of hydroxyapatite (HA) after immersion in simulated body fluid (SBF) and to test the initial attachment of human osteoblasts within the porous network. It was found that crystalline HA formed on the Bioglass® coated PDLLA foams after 7 days of immersion in SBF. HA formed also on the surfaces of non‐coated PDLLA foams, however the rate and amount of HA formation were much lower than in the composites. The rapid formation of HA on the Bioglass®/PDLLA foam surfaces confirmed the high bioactivity of these materials. Osteoblasts attached within the porous network throughout the depth of the foams. Cell density was found to be higher in the PDLLA/Bioglass® composites compared to the pure PDLLA foams. The composite foams developed here exhibit the required bioactivity to be used as scaffolds for bone tissue engineering.     

An in-vitro Investigation of Iron-Containing Hydroxyapatite/Titanium Composites

The in-vitro biological behavior of a newly-developed iron-containing hydroxyapatite/titanium(HA/Ti) composite was investigated by immersing the composites in the simulated body fluid(SBF) for up to 5 weeks.The addition of iron was observed to have a significant influence on the in-vitro biological behavior of the composites.The obtained results revealed that the stability of the composites in the physiological solution was markedly improved.The solubility decreased in the order of pure HA,HA/5(Ti-33Fe),and HA/15(Ti33Fe).Precipitation occurred on the surface of HA/5(Ti-33Fe) composite,showing a good combination of physiostability with bioactivity,while HA/15(Ti-33Fe) composite exhibited superior physiostability since there was no obvious change on the surface of HA/15(Ti-33Fe).     

Preparation and properties of a novel bone repair composite: nano-hydroxyapatite/chitosan/carboxymethyl cellulose

Nano-hydroxyapatite/chitosan/carboxymethyl cellulose (n-HA/CS/CMC) composites with weight ratios of 70/10/20, 70/15/15 and 70/20/10 were prepared through a co-solution method. The properties of the composites were characterized by means of burn-out test, IR, XRD, TEM and universal material testing machine. The degradation and bioactivity were also investigated by in vitro test in a simulated body fluid (SBF) for 8 weeks. The results showed that n-HA particles were dispersed uniformly in organic phase, and strong chemical interactions formed among the three phases. Moreover, the composites were similar to natural bone in morphology and size. In addition, the compressive strength was improved compared with n-HA/CS composite. The biodegradation rate was controllable by altering weight ratio of the CS/CMC. Meanwhile, the composites could induce apatite particles to deposit in SBF. All the above results indicate that the novel composites of n-HA/CS/CMC have a promising prospect used for bone repair materials in view of the good mechanical property, adjustable biodegradation rate and bioactivity in SBF. Additionally, the study would provide a good guide to exploit clinical application of natural cellulose.     

The fabrication of nanocomposites via calcium phosphate formation on gelatin–chitosan network and the gelatin influence on the properties of biphasic composites

A novel biodegradable polymer–ceramic nanocomposite which consisted of gelatin (Gel), chitosan (CS), and calcium phosphate (CaP) nanoparticles was prepared based on in situ preparation method. The fabricated biocomposites were characterized by FTIR, X-ray diffraction (XRD), transmission electron microscopy (TEM) as well as scanning electron microscope with X-ray elemental analysis (SEM-EDX). The characterization results confirmed that the crystalline calcium phosphate nanoparticles were mineralized in polymeric matrix and the interaction between Ca2+ in calcium phosphate and functional groups in polymers molecular chains was formed. XRD result showed that in addition to hydroxyapatite (HA), Brushite (BR) and tricalcium phosphate (β-TCP) particles also were formed due to lack of complete penetration of the basic solution into the polymeric matrix. However, SEM image indicated that the polymeric matrix has the controlling role in the particle size of calcium phosphate. The size of particles in three component composites was about 100 nm while in two component composites proved to be more in μm size. TEM observation supported SEM results and showed that the three component composites have calcium phosphate nanoparticles. The elastic modulus and compressive strength of the composites were also improved by the employment of gelatin and chitosan together, which can make them more beneficial for surgical applications.     

Fabrication and corrosion behavior of HA/Mg-Zn biocomposites

The thermal-treated hydroxyapatite (HA) particles, Mg and Zn powders were used to prepare the HA/Mg-Zn composites with different HA contents by means of powder metallurgy technology. The microstructures, formation phases, and corrosion behaviors in simulated body fluid (SBF) were studied in comparison with pure magnesium and HA/Mg composites fabricated by the same preparation technology. As a result, no evident reaction happened between HA particles and Mg matrix during sintering process, and Zn atoms diffused into Mg matrix to form a single phase Mg-Zn alloy matrix. The addition of HA particles changed the corrosion mechanism of Mg matrix. During the corrosion process, HA particles would adsorb PO₄³⁻ and Ca²⁺ ions efficiently and induce the deposition of Ca-P compounds on the surface of composites. HA could improve the corrosion resistance of magnesium matrix composites in SBF and restrain the increase of pH of SBF. Furthermore, the addition of Zn was favorable to improve the corrosion resistance of HA/Mg composites due to the densification of composites and the formation of Mg-Zn alloy matrix.     

Biodegradation and compressive strength of phosphorylated chitosan/chitosan/hydroxyapatite bio-composites

The research about how to obtain an organic/inorganic bio-composite with excellent comprehensive properties is an active research field. Nowadays, very few of the achievements were applied to the clinical use due to many reasons. In this work, the purpose was to get a three-phase composite with good compressive strength by using phosphorylated chitosan. Phosphorylated modification of chitosan would bring new properties such as metal chelating. Four phosphorylated chitosan/chitosan/hydroxyapatite (PCS/CS/HA) composites with the weight ratios of 40/40/20, 30/30/40, 20/20/60, 10/10/80 were prepared through the coprecipitation method. The maximum value of compressive strength was measured about 70.25 MPa corresponding to the PCS/CS/HA composite rod with a weight ratio of 30/30/40. The composite rod maintained 64% of original compressive strength after soaking in simulated body fluid for 20 days. All the results showed that the PCS/CS/HA composite (30/30/40), had a good compressive strength, was appropriate to be used as a novel bio-composite for bone tissue engineering.     

Microwave assisted-in situ synthesis of porous titanium/calcium phosphate composites and their in vitro apatite-forming capability

Microwave irradiation has been proven to be an effective heating source in synthetic chemistry, and can accelerate the reaction rate, provide more uniform heating and help in developing better synthetic routes for the fabrication of bone-grafting implant materials. In this study, a new technique, which comprises microwave heating and powder metallurgy for in situ synthesis of Ti/CaP composites by using Ti powders, calcium carbonate (CaCO₃) powders and dicalcium phosphate dihydrate (CaHPO₄·2H₂O) powders, has been developed. Three different compositions of Ti:CaCO₃:CaHPO₄·2H₂O powdered mixture were employed to investigate the effect of the starting atomic ratio of the CaCO₃ to CaHPO₄·2H₂O on the phase, microstructural formation and compressive properties of the microwave synthesized composites. When the starting atomic ratio reaches 1.67, composites containing mainly alpha-titanium (α-Ti), hydroxyapatite (HA), beta-tricalcium phosphate (β-TCP) and calcium titanate (CaTiO₃) with porosity of 26%, pore size up to 152 μm, compressive strength of 212 MPa and compressive modulus of 12 GPa were formed. The in vitro apatite-forming capability of the composite was evaluated by immersing the composite into a simulated body fluid (SBF) for up to 14 days. The results showed that biodissolution occurred, followed by apatite precipitation after immersion in the SBF, suggesting that the composites are suitable for bone implant applications as apatite is an essential intermediate layer for bone cells attachment. The quantity and size of the apatite globules increased over the immersion time. After 14 days of immersion, the composite surface was fully covered by an apatite layer with a Ca/P atomic ratio approximately of 1.68, which is similar to the bone-like apatite appearing in human hard tissue. The results suggested that the microwave assisted-in situ synthesis technique can be used as an alternative to traditional powder metallurgy for the fabrication of Ti/CaP biocomposites.     

Novel bioresorbable and bioactive composites based on bioactive glass and polylactide foams for bone tissue engineering

Bioresorbable and bioactive tissue engineering scaffolds based on bioactive glass (45S5 Bioglass®) particles and macroporous poly(DL-lactide) (PDLLA) foams were fabricated. A slurry dipping technique in conjunction with pretreatment in ethanol was used to achieve reproducible and well adhering bioactive glass coatings of uniform thickness on the internal and external surfaces of the foams. In vitro studies in simulated body fluid (SBF) demonstrated rapid hydroxyapatite (HA) formation on the surface of the composites, indicating their bioactivity. For comparison, composite foams containing Bioglass® particles as filler for the polymer matrix (in concentration of up to 40 wt %) were prepared by freeze-drying, enabling homogenous glass particle distribution in the polymer matrix. The formation of HA on the composite surfaces after immersion in phosphate buffer saline (PBS) was investigated to confirm the bioactivity of the composites. Human osteoblasts (HOBs) were seeded onto as-fabricated PDLLA foams and onto PDLLA foams coated with Bioglass® particles to determine early cell attachment and spreading. Cells were observed to attach and spread on all surfaces after the first 90 min in culture. The results of this study indicate that the fabricated composite materials have potential as scaffolds for guided bone regeneration.     

Preparation and in vitro bioactivity of poly(d,l-lactide) composite containing hydroxyapatite nanocrystals

The nano-sized hydroxyapatite (n-HA) was incorporated into poly(d,l-Lactide) (PDLLA) to form a bioactive and biodegradable composite for application in hard tissue replacement and regeneration. Thin film of PDLLA composite containing 20 mass% of n-HA fillers was successfully developed through integration of solvent co-blending and hot pressing techniques. firstly, n-HA and PDLLA were chemically synthesized, respectively, then mixed together and homogeneously dispersed in N,N-dimethyl formamide(DMF) solvent, finally, the dried blended hybrid containing PDLLA matrix and n-HA fillers was put into the mould and compacted by hot-pressing machine under 8 MPa pressure at 110 °C for 15 min. In vitro studies were conducted using the simulated body fluid(SBF). Composite specimens were soaked in SBF from 1 day to 21 days prior to surface analysis. Results obtained from scanning electron microscopy(SEM) examination, Energy dispersive X-ray detector(EDX) analysis and X-ray diffraction (XRD) analysis showed that a layer of non-stoichiometric apatite formed within 7 days on HA/PDLLA composite surface after its immersion in SBF, demonstrating moderate in vitro bioactivity of n-HA/PDLLA composite, though a moderate rate of apatite formation in SBF was found on initial stage of immersion periods for n-HA/PDLLA composite, compared to the other biomaterial composite. This type of composite film exhibited certain desirable bioactive characteristics, and they are promising bone candidates to develop novel bioactive composites for biomedical application.     

Ti35Nb7Zr-xHA生物复合材料的微观组织与性能研究

为了改善Ti-Nb-Zr合金的生物活性,采用放电等离子烧结(SPS)技术制备了不同羟基磷灰石(HA)含量的Ti35Nb7Zr-xHA(x=0、5、10、20(质量分数,%))生物复合材料,研究了HA含量对复合材料微观组织、力学性能及体外生物活性的影响。结果表明,复合材料主要由β-Ti、α-Ti、HA及陶瓷相(Ti_xP_y、CaTiO_3、Ti_2O、CaO)组成;HA含量增加会导致β-Ti减少而α-Ti和陶瓷相明显增多;与Ti-35Nb-7Zr合金(E:45GPa,σ:1 736 MPa)相比,HA含量为5%和10%时,复合材料的抗压强度分别为1 662MPa和1 593MPa,弹性模量分别为48GPa和49GPa,综合力学性能与Ti-35Nb-7Zr合金接近,展现出良好的力学性能,而过高的HA含量(20%)会导致复合材料弹性模量明显升高(E:55GPa)、抗压强度急剧下降(σ:958 MPa),复合材料的力学性能降低;体外生物活性实验表明,加入10%HA的复合材料在人工模拟体液(SBF)中浸泡7d后表面生成了大量的类骨磷灰石层,与Ti-35Nb-7Zr合金相比,其显示出更优异的体外生物活性。